UK FinTech Funding Drops to Lowest Level in Decade
U.K. FinTech investments have reached a 10-year low amid an overall jump in funding. British financial technology firms…
UK financial system strengthened with new safeguards for major technology providers | HM Treasury
Government has designated four major global cloud services and technology providers as Critical Third Parties (CTPs). Four global…
Worst global money exodus barely bruises India
A man walks near a screen outside the Bombay Stock Exchange (BSE) in Mumbai, India, August 28, 2025.…
Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
Supporting the advancement of modular infrastructure in the UK
As urbanisation accelerates worldwide, the pressure to deliver efficient, sustainable and scalable building solutions is intensifying – giving…
Are Small Caps Finally Back?
Are Small Caps Finally Back? By Timothy C. Murray, CFA Download the PDF U.S. small-cap stocks have…
China soaks up the crude oil glut, but only if the price is right
LAUNCESTON, Australia, Jan 27 (Reuters) – Where exactly is the expected supply glut in the global crude market?…
‘Very deep poverty’ in Britain hits record high, new report finds
LONDON, Jan 27 (Reuters) – Poverty in Britain has deepened, according to a report released on Tuesday, with…
Dollar under fire again as investors reassess Trump policies, geopolitical risk
Trump’s policies create volatility, hurt dollar, investors sayFed expected to cut rates, undermining dollar appealInvestors diversifying away from…
US climber scales Taiwan’s tallest building Taipei 101 without ropes
‘Free solo’ ascent organised and shown live by NetflixHonnold completed climb in an hour and a halfTaipei 101…
Sovereign AI Selects Accenture and Palantir to Help Build Next Generation AI Infrastructure Across EMEA
S-AI aims to address the rapidly expanding need for advanced AI infrastructure as a critical foundation for industrial…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…